Vasomotor Menopausal Symptoms (VMS) Treatment Market Trends, Share, and Forecast By 2030

Comments · 11 Views

Data Bridge Market Research analyses a growth rate in the vasomotor menopausal symptoms (VMS) treatment market in the forecast period 2023-2030. The expected CAGR of vasomotor menopausal symptoms (VMS) treatment market is around 6.20% in the mentioned forecast period. The market was valued

"In the dependable  Vasomotor Menopausal Symptoms (VMS) Treatment Market document, all gathered data undergoes study and analysis using demonstrated tools and techniques like SWOT analysis and Porter's Five Forces analysis. The report encompasses various aspects of marketing research and analysis for the Vasomotor Menopausal Symptoms (VMS) Treatment Market industry, including market size estimations, market dynamics, best practices in the industry, entry-level marketing strategies, positioning and segmentations, competitive landscaping, opportunity analysis, economic forecasting, industry-specific technology solutions, roadmap analysis, targeting key buying criteria, and in-depth benchmarking of vendor offerings. The research report also examines key developments in the market concerning the current scenario and forthcoming advancements.

In the winning Vasomotor Menopausal Symptoms (VMS) Treatment Market report, a thorough investment analysis forecasts imminent opportunities for market players and develops strategies to enhance return on investment (ROI). The report focuses on important aspects, including historic data, present market trends, the environment, technological innovation, upcoming technologies, and technical progress in the related industry. A team of enthusiastic, groundbreaking, dynamic, and skilled researchers and analysts consistently works to provide clients with the supreme Vasomotor Menopausal Symptoms (VMS) Treatment Market research report.

As per the North American Menopause Society, up to 75% of females in the U.S. witness hot flashes around menopause. Vasomotor symptoms (VMS), including night sweats and hot flashes, are observed in around 68.5% of women as a result of menopause. The median duration of these symptoms is approximately 4 years, though around 10% of women continue to experience VMS as many as 12 years. The increasing incidence of vasomotor and menopausal symptoms such as hot flashes and night sweats among women during menopausal transition is anticipated to boost the market growth.

Data Bridge Market Research analyses a growth rate in the vasomotor menopausal symptoms (VMS) treatment market in the forecast period 2023-2030. The expected CAGR of vasomotor menopausal symptoms (VMS) treatment market is around 6.20% in the mentioned forecast period. The market was valued at USD 16.71 billion in 2022, and it would grow up to USD 27.03 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Explore Further Details about This Research Vasomotor Menopausal Symptoms (VMS) Treatment Market Report https://www.databridgemarketresearch.com/reports/global-vasomotor-menopausal-symptoms-vms-treatment-market

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Drug Class (Antidepressants, Hormone Therapy, Anticonvulsant, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Zhejiang Huahai Pharmaceutical Co., Ltd (China), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc (U.S.), Hikma Pharmaceutical PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Alembic Pharmaceuticals Limited (India), Zydus Group (India), Dr. Reddy’s Laboratories Ltd (India), Abbvie, Inc (U.S.), Sun Pharmaceutical Industries Ltd (India), Apotex Inc (Canada), Aurobindo Pharma (India), Endo Pharmaceuticals plc (Ireland), Lupin (India), Novartis AG (Switzerland), and WOCKHARDT (India)

Market Opportunities

  • Increasing Adoption of OTC Drugs
  • Increasing Financial Support from Several Organizations

Market Definition

Vasomotor menopausal symptoms (VMS) are a type of rash which affects the area around the mouth and causes inflammation. The rash will extend up the nose or even into the eyes. The common symptom of this condition is a scaly or red bumpy rash. Lesions on darker skin can be hyperpigmented or brown. Antibiotics can be advantageous for a few weeks, whether oral or topically. Azelaic acid is a prescription-only topical medication. When treatment is disturbed, the problem may reoccur, but the same therapy can be restarted as needed.  

Vasomotor Menopausal Symptoms (VMS) Treatment Market Dynamics

Drivers

  • Increase in Menopause Population

The rise in the number of menopausal women which demands treatment for hot flashes and vaginal dryness globally is one of the primary factors pushing the growth of the vasomotor menopausal symptoms (VMS) treatment market. According to a study published in the International Journal of Applied & Basic Medical Research, about 36.7% of women stated hot flashes among 87.7% of women resulting in menopausal symptoms. As per the North American Menopause Society, around 6,000 women in the U.S. reach menopause every day, and about 2 million women per year. The UN data shows around 985 million women aged 50 years and above in 2020. This number is anticipated to reach 1.65 billion by 2050. Thus,this increasing population will rise the different symptoms of menopause and thus will expand the growth of the market.

Opportunities

  • Increasing Financial Support by Several Organizations

Numerous public and private organizations are rising their investments in developing novel interventions and treatments which further boost the market growth. Increasing investment in the treatment of menopausal manifestation is anticipated to increase the market. For instance, Bayer AG started the phase III clinical program OASIS in 2021. Under the program, elinzanetant, a dual neurokinin-1,3 receptor antagonist, will be assessed on the standards of efficacy and safety for treating menopausal symptoms such as vasomotor symptoms

What insights readers can gather from the Vasomotor Menopausal Symptoms (VMS) Treatment Market report?

  • Learn the behavior pattern of every Vasomotor Menopausal Symptoms (VMS) Treatment Market -product launches, expansions, collaborations and acquisitions in the market currently.
  • Examine and study the progress outlook of the global  Vasomotor Menopausal Symptoms (VMS) Treatment Market landscape, which includes, revenue, production & consumption and historical & forecast.
  • Understand important drivers, restraints, opportunities and trends (DROT Analysis).
  • Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.

Browse Related Reports:

Medical Cannabis Extraction  Market is Likely to Upsurge at Billion Globally by  Size, Share, Trends, Demand, Growth and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-medical-cannabis-extraction-market

Automated Hospital Beds  Market To Perceive Highest Growth of Billion by Size, Share, Trends, Key Growth Drivers and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-automated-hospital-beds-market

Advanced Visualization  Market to Receive Billion by Size, Shares, Trends, Demand, Growth Opportunities and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-advanced-visualization-market

Protein Expression  Market to Experience Substantial Growth of Billion by  Size, Share, Demand, Opportunities, Growth Rate and Key Players Analysis

https://www.databridgemarketresearch.com/reports/global-protein-expression-market

STD Testing  Market is expected to Reach the Valuation Billion by Size, Share, Growth, Trends, Demand and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-std-testing-market

Smart Thermometers  Market to Grasp Outstanding Growth of Million by, Size, Share, Trends, Opportunities, Key Drivers and Revenue Forecast

https://www.databridgemarketresearch.com/reports/global-smart-thermometers-market

Fusion Protein  Market to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-fusion-protein-market

Pain Relief Therapy  Market is Probable to Influence the Value of Billion by Size, Share, Trends, Industry Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-pain-relief-therapy-market

Autoimmune Treatment  Market to Receive Highest Growth of Billion by Size, Shares, Trends, Future Demand, Growth and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-autoimmune-treatment-market

Bariatric Surgery Devices  Market to Grasp Outstanding Growth of Billion by Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

https://www.databridgemarketresearch.com/reports/global-bariatric-surgery-devices-market

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com

 

Comments